Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DACLIZUMAB
- Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)
- Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab
- Study Comparing Efficacy and Safety of Mycophenolate Mofetil (Cellcept) With Delayed Introduction of Sirolimus and Discontinuation of Cyclosporine, With Those of Mycophenolate Mofetil and Long Term Continuation of Cyclosporine in Renal Transplant Re
- A Study to Assess Immune Response in Pediatric Kidney Transplant Recipients Treated With Daclizumab (Zenapax)
- A Study of Daclizumab (Zenapax) in Combination With Mycophenolate Mofetil (CellCept) and Sirolimus in Prevention of Acute Rejection in Heart Transplant Participants
- Simulect Versus ATG in Sensitized Renal Transplant Patient
- Trial of Adoptive Immunotherapy With TRACT to Prevent Rejection in Living Donor Kidney Transplant Recipients
- Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019
- Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate Sodium
- Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease
- Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma
- An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis
- Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab)
- Randomized Trial of 2 Antibody Induction Steroid Avoidance Protocols
- Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis
- Pre Transplant Rapamycin Treatment in Islet Transplantation Alone
- Thymoglobulin Versus Alemtuzumab Versus Daclizumab in Living Donor Renal Transplantation
- Comparison of Tacrolimus and Myfortic Versus Tacrolimus and Sirolimus
- A Study of Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)
- Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia
- Minimizing Immunosuppression in Old for Old Kidney Transplantation
- Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) in Participants With Multiple Sclerosis Who Have Completed Study 205MS201 (NCT00390221) to Treat Relapsing-Remitting Multiple Sclerosis
- Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists
- Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients
- Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant
- Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX
- Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Deceased Donor Renal Transplantation
- Daclizumab Versus Thymoglobulin in Renal Transplant Recipients With High Immunological Risk
- Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Living Donor Renal Transplantation
- Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery
- Phase I/II Thymus Transplantation With Immunosuppression #950
- Rituximab for GVHD
- Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD
- Pancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment
- Fibrosis in Renal Allografts
- B-Lymphocyte Immunotherapy in Islet Transplantation
- LEA29Y (Belatacept) Emory Edmonton Protocol
- Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes
- Safety and Efficacy Study of Daclizumab High Yield Process (DAC HYP) to Treat Relapsing-Remitting Multiple Sclerosis
- A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients
- Combination Daclizumab/Denileukin Diftitox to Treat Uveitis
- Comparison of Sirolimus and Azathioprine in Lung Transplantation
- Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys
- Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal Grafts
- Simultaneous Pancreas-kidney Transplantation With Campath Protocol
- Islet Cell Transplantation Alone and CD34+ Donor Bone Marrow Cell Infusion in Type 1 Diabetes Mellitus
- Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free Immunosuppression
- Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration
- Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney Transplantation
- Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients
- Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.
- Renal Function Optimization With Mycophenolate Mofetil (MMF) Immunosuppressor Regimes (ALHAMBRA)
- Use of Daclizumab for the Prevention of Allograft Rejection in Pediatric Heart Transplant Patients
- The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients.
- Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch
- CamTac Trial:Campath-Tacrolimus vs IL2R MoAb/Tacrolimus/MMF in Renal Transplantation
- MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant Patients
- Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis
- Prevention of Diabetes Progression Trial (PDPT)
- Study Evaluating Sirolimus in Kidney Transplant Recipients
- The Use of Daclizumab and Anti-Thymocyte Globulin in Lung Transplantation
- Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection
- Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation
- Multicenter Uveitis Steroid Treatment (MUST) Trial
- Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated Uveitis
- Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis
- New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial
- Daclizumab to Treat HIV-Infected Patients
- Daclizumab and Sirolimus to Treat Uveitis
- Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis
- A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)
- Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis
- Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis
- Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes
- Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease
- To Study the Use of Humanized CD25 in Preventing the Relapse of Psoriasis Vulgaris
- To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris
- Daclizumab to Treat Chronic Immune Thrombocytopenia
- A Study to Evaluate the Efficacy and Safety of Zenapax in Combination With CellCept, Cyclosporine, and Corticosteroids in Patients Undergoing Cardiac Transplantation
- A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients
- Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis
- Daclizumab to Treat Wegener's Granulomatosis
- Study of Daclizumab in Patients With Chronic, Persistent Asthma
- Pediatric Kidney Transplant Without Calcineurin Inhibitors
- Monoclonal Antibody Therapy in Treating Patients With Leukemia
- Islet Transplantation for Type 1 Diabetes
- Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression
- Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
- A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure
- HAT in Eye Complications of Behcet's Disease
- ANTI-TAC THERAPY FOR UVEITIS
Clinical trials list
click for details